Home > Investor

Investor

Share Trends
Stock Performance
Warsaw Stock Exchange
Bulgarian Stock Exchange
Corporate News
28 October 2021
The Executive Director of Sopharma met with Vice President of Vietnam Mrs. Vo Thi Anh Xuan
Financial News
2 July 2025
Notification of sale of treasury shares as of 2 July, 2025
1 July 2025
Notification on the conclusion of a transaction under the application of Article 114, paragraph 2 of the LPOS
30 June 2025
Notification of sale of treasury shares as of 30 June, 2025
Financial Highlights 31 March, 2022
397 570
BGN '000 Revenue
34 368
BGN '000 EBITDA
21 827
BGN '000 Revenue from operating profit
22 560
BGN '000 Net profit for the year
0.17
BGN Earnings per share

Next events
21 July 2025
Revenues for January-June 2025
30 July 2025
Publication of the Individual financial statements for Q2 of 2025

Equity story

85+ year track record in the pharma industry

  • Leadership
  • Growth
  • Portfolio
  • Profitability
  • Business Model
  • M&A